PRF Technologies PRFX
NASDAQ PRFX
$0.84 -0.03 (-3.16%)
As of: Nov 9, 2026 · 11:26 AM EST

PRF Technologies (PRFX) Beginning Cash Balance (2022 - 2023)

Updated

Analysis

PRF Technologies (PRFX) Beginning Cash Balance (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,245.06 Bn 1,218.68 Bn 20.46 Bn
2 Johnson & Johnson 673.03 Bn 592.89 Bn 17.30 Bn
3 AbbVie 516.90 Bn 484.91 Bn 13.12 Bn
4 Merck 364.03 Bn 326.97 Bn 13.19 Bn
5 Novartis Ag 315.15 Bn 288.38 Bn -
6 Astrazeneca 292.21 Bn 266.10 Bn 13.26 Bn
7 Amgen 250.55 Bn 202.21 Bn 7.58 Bn
8 Gilead Sciences 210.41 Bn 185.52 Bn 6.73 Bn
9 Pfizer 166.92 Bn 114.28 Bn 12.56 Bn
10 PRF Technologies 546,370.85 -22.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 4.11 Mn
Sep 30, 2022 16.57 Mn
API Access

PRF Technologies Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=PRFX&period=max&api_key=YOUR_API_KEY